In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ionix Pharmaceuticals Ltd.

Division of Ligand Pharmaceuticals Inc.
www.ionixpharma.com

Latest From Ionix Pharmaceuticals Ltd.

Bicycle Therapeutics appoints non-executive chairman

Cambridge-based biotech Bicycle Therapeutics has appointed Andy Sandham as non-executive chairman. Mr Sandham held previous roles at Cantab Pharmaceuticals, Hexagen, Signature BioScience and Ionix Pharmaceutials, and continues to serve as chairman and CEO of Kymab and non-executive director of NeurAxon and PBL.

Wellcome Trust financing sets Kymab on course

A £20 million series A equity financing by The Wellcome Trust's investment division has given Kymab, a spin-out from the Trust's Sanger Institute in Cambridge, UK, the financial means to "build a substantial biopharmaceutical enterprise over the next decade", said chairman and CEO Andrew Sandham.

Companies Deals

Trade Sales Trump IPOs, Even for Platforms

Europe's summertime flurry of private biotech sell-offs points to growing pragmatism among management and VCs, and still-poor valuations on the public markets. Firms which haven't already considered the trade sale opportunity should do so--even early-stage, pre-product platform groups.
BioPharmaceutical Strategy

European Biotech Is Specialty Pharma

Europe's investment environment has forced much of the biotech sector to morph into specialty pharma. The situation isn't likely to change fast. Executives had best adapt, rather than complain.
BioPharmaceutical Europe
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Ligand Pharmaceuticals Inc.
  • Senior Management
  • Andrew P Sandham, Pres. & CEO
    Kelly Chessman, Fin. Controller
    Phillip J Birch, CSO
    Nigel M Low, PhD, Dir., Bus. Dev.
  • Contact Info
  • Ionix Pharmaceuticals Ltd.
    Phone: (44) 1223 433 777
    Cambridge Scicence Park, Unit 418
    Milton Rd.
    Cambridge, CB4 0PA
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register